Jamie Mullen
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,454 of the $2,751 with a category attached, or 89.2%. It is spread thinly across 34 manufacturers, the largest accounting for just 16.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $996 and has fallen 69.5% since, to $304 in 2025.
Across 119 payments — averaging $23.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$450
- AbbVie$396
- Novartis$353
- Incyte Corporation$159
- Gilead$139
- Johnson & Johnson$118
- plus $1K from 28 others
What the payments were for
- Food & beverage$2,45489%
- Education$29711%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 11 | $450 |
| AbbVie | 19 | $396 |
| Novartis | 16 | $353 |
| Incyte Corporation | 5 | $159 |
| Gilead(2 entities) | 6 | $139 |
| Johnson & Johnson | 5 | $118 |
| Sanofi | 6 | $107 |
| CSL Behring | 6 | $101 |
| Janssen Scientific Affairs, LLC | 1 | $84 |
| Ipsen Biopharmaceuticals, Inc | 4 | $80 |
| Beone Medicines USA, Inc. | 3 | $76 |
| Merck | 3 | $73 |
| Pharmacyclics LLC, An Abbvie Company | 3 | $71 |
| Daiichi Sankyo Inc. | 3 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $52 |
| Jazz Pharmaceuticals Inc. | 3 | $48 |
| Lilly USA, LLC | 2 | $45 |
| Seagen Inc. | 3 | $42 |
| AVEO Pharmaceuticals, Inc. | 2 | $35 |
| Deciphera Pharmaceuticals Inc. | 2 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Pfizer | 1 | $18 |
| Eisai Inc. | 1 | $18 |
| Bristol Myers Squibb | 1 | $17 |
| Puma Biotechnology, Inc. | 1 | $17 |
| Beigene USA, Inc. | 1 | $16 |
| Myovant Sciences Inc. | 1 | $16 |
| Array Biopharma Inc | 1 | $16 |
| Karyopharm Therapeutics Inc. | 1 | $16 |
| Sobi, Inc | 1 | $16 |
| Bayer | 1 | $15 |
| GE HealthCare | 1 | $14 |
| Acceleron Pharma, Inc. | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IMFINZI$125
How this compares
$2,751 in reported general payments places this provider in the 85th percentile of 14,618 family providers in Florida.
Other family in Tampa
- Lewis HarringtonTampa$954K
- Marie Labadie-DegennaroTampa$66K
- Polly BittleTampa$63K
- Katharine WilliamsTampa$47K
- Candace DeberryTampa$46K
- Bailey BlankenshipTampa$42K
- Rasheeta ChandlerTampa$37K
- Rosaly TorresTampa$28K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.